Oftentimes, you can make a lot more money over the long run by finding stocks that aren’t as widely followed.
In the first quarter of 2020, Ayr generated revenue of $58.4 million, up 74% year over year.
Ayr now has a major presence in Florida’s medical cannabis market thanks to its acquisition of Liberty Health Sciences.
With the company’s sales growth set to accelerate, I think Ayr is a stock that could realistically double in the second half of 2021.
Jushi’s market cap remains below $1 billion, but I think this company will be worth a lot more than that within the next few years.
This stock isn’t as cheap as Ayr and Jushi with a price-to-sales multiple of over 14.